治疗药物监测市场－全球产业规模、份额、趋势、机会及预测（按药物类别、技术、地区和竞争细分，2020-2030 年）

2024年，全球治疗药物监测市场规模达15亿美元，预计2030年将达18.2亿美元，年复合成长率达3.47%。治疗药物监测 (TDM) 是精准医疗的重要组成部分，它使临床医生能够测量血液中的药物浓度，从而製定最佳安全性和有效性的治疗方案。 TDM 对于治疗窗口窄或个体代谢差异大的药物尤其重要。随着癫痫、癌症、心血管疾病和自体免疫疾病等慢性疾病发生率的上升，常规药物监测的需求日益凸显。接受长期治疗（尤其是使用免疫抑制剂、抗生素或抗癫痫药物）的患者需要频繁监测，以维持疗效并避免不良反应。儘管有这种需求，但市场仍面临许多障碍，例如设备成本高、对技术专长的需求，以及由于资源限制和认知度低，发展中地区的应用有限。

关键市场驱动因素

医疗保健产业的成长

主要市场挑战

测试和基础设施成本高昂

主要市场趋势

个人化医疗需求不断成长

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19 对全球治疗药物监测市场的影响

第五章：全球治疗药物监测市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依药物类别（抗癫痫药、抗生素药、免疫抑制剂、抗心律不整药、支气管扩张药、精神活性药物、其他）
  • 依技术（免疫测定、化学发光免疫测定、比色免疫测定、萤光免疫测定、放射免疫测定、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美治疗药物监测市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲治疗药物监测市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区治疗药物监测市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲治疗药物监测市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲治疗药物监测市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第十三章：干扰：衝突、流行病与贸易壁垒

第 14 章：全球治疗药物监测市场：SWOT 分析

第 15 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 16 章：竞争格局

• Roche AG
• Siemens Healthcare GmbH
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Beckman Coulter, Inc.
• Abbott Laboratories, Inc.
• Agilent Technologies, Inc.
• bioMerieux, Inc.
• Alere, Inc.

第 17 章：策略建议

第18章调查会社について・免责事项

The Global Therapeutic Drug Monitoring Market was valued at USD 1.50 Billion in 2024 and is projected to reach USD 1.82 Billion by 2030, expanding at a CAGR of 3.47%. Therapeutic Drug Monitoring (TDM) is a critical component of precision medicine, enabling clinicians to measure drug levels in the bloodstream to tailor treatment for optimal safety and efficacy. TDM is particularly important for medications with narrow therapeutic windows or variable metabolism across individuals. With rising incidences of chronic conditions such as epilepsy, cancer, and cardiovascular and autoimmune diseases, the need for routine drug monitoring is becoming more pronounced. Patients undergoing long-term treatments-especially with immunosuppressants, antibiotics, or antiepileptic drugs-require frequent monitoring to maintain therapeutic effectiveness while avoiding adverse effects. Despite this demand, the market encounters hurdles, such as the high cost of equipment, the need for technical expertise, and limited adoption in developing regions due to resource constraints and low awareness.

Key Market Drivers

Growth in Healthcare Industry

The ongoing expansion of the global healthcare sector, with annual revenues exceeding USD 4 trillion, is a key catalyst for the therapeutic drug monitoring market. Pharmaceuticals and biotechnology contribute nearly USD 850 billion, while medical technology and diagnostics generate over USD 400 billion. As healthcare systems worldwide evolve toward precision-driven, patient-centric models, TDM is gaining importance for its ability to optimize treatment efficacy and minimize adverse drug reactions. Growing emphasis on individualized therapy and safe medication practices positions TDM as an integral part of modern clinical care protocols.

Key Market Challenges

High Cost of Testing and Infrastructure

The substantial cost associated with implementing and maintaining TDM capabilities represents a significant challenge for broader adoption. Establishing a dedicated TDM facility necessitates advanced instruments such as liquid chromatography-mass spectrometry (LC-MS), immunoassay analyzers, and robust data management systems. These high capital investments are coupled with recurring expenses related to maintenance, quality control, and skilled labor. Additionally, compliance with stringent regulatory and quality standards further escalates the cost of infrastructure. These barriers are particularly restrictive for smaller healthcare facilities and institutions in developing economies.

Key Market Trends

Rising Demand for Personalized Medicine

A major trend shaping the TDM market is the increasing adoption of personalized medicine, valued globally at approximately USD 512 billion in 2022. Personalized medicine aims to deliver treatments tailored to an individual's genetic profile, lifestyle, and physiological response. In this context, TDM serves as a vital enabler by allowing healthcare professionals to monitor drug concentrations in real-time, ensuring therapeutic levels are achieved without toxicity. This is especially crucial for drugs with narrow therapeutic indices. The convergence of TDM with pharmacogenomics and precision diagnostics is reinforcing its role in developing more accurate, patient-specific treatment regimens, ultimately enhancing clinical outcomes.

Key Market Players

• Roche AG
• Siemens Healthcare GmbH
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Beckman Coulter, Inc.
• Abbott Laboratories, Inc.
• Agilent Technologies, Inc.
• bioMerieux, Inc.
• Alere, Inc.

Report Scope

In this report, the Global Therapeutic Drug Monitoring Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Therapeutic Drug Monitoring Market, By Drug Class:

• Antiepileptic Drug
• Antibiotic Drug
• Immunosuppressant Drug
• Antiarrhythmic Drug
• Bronchodilator Drug
• Psychoactive Drug
• Others

Therapeutic Drug Monitoring Market, By Technology:

• Immunoassay
• Chemiluminescence Immunoassay
• Colorimetric Immunoassay
• Fluorescence Immunoassay
• Radioimmunoassay
• Others

Therapeutic Drug Monitoring Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Therapeutic Drug Monitoring Market.

Available Customizations

Global Therapeutic Drug Monitoring Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Therapeutic Drug Monitoring Market

5. Global Therapeutic Drug Monitoring Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Drug Class (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, Others)
  • 5.2.2. By Technology (Immunoassay, Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence Immunoassay, Radioimmunoassay, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Therapeutic Drug Monitoring Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Drug Class
  • 6.2.2. By Technology
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Therapeutic Drug Monitoring Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Drug Class
      • 6.3.1.2.2. By Technology
  • 6.3.2. Mexico Therapeutic Drug Monitoring Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Drug Class
      • 6.3.2.2.2. By Technology
  • 6.3.3. Canada Therapeutic Drug Monitoring Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Drug Class
      • 6.3.3.2.2. By Technology

7. Europe Therapeutic Drug Monitoring Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Drug Class
  • 7.2.2. By Technology
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Therapeutic Drug Monitoring Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Drug Class
      • 7.3.1.2.2. By Technology
  • 7.3.2. Germany Therapeutic Drug Monitoring Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Drug Class
      • 7.3.2.2.2. By Technology
  • 7.3.3. United Kingdom Therapeutic Drug Monitoring Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Drug Class
      • 7.3.3.2.2. By Technology
  • 7.3.4. Italy Therapeutic Drug Monitoring Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Drug Class
      • 7.3.4.2.2. By Technology
  • 7.3.5. Spain Therapeutic Drug Monitoring Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Drug Class
      • 7.3.5.2.2. By Technology

8. Asia Pacific Therapeutic Drug Monitoring Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Drug Class
  • 8.2.2. By Technology
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Therapeutic Drug Monitoring Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Drug Class
      • 8.3.1.2.2. By Technology
  • 8.3.2. India Therapeutic Drug Monitoring Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Drug Class
      • 8.3.2.2.2. By Technology
  • 8.3.3. South Korea Therapeutic Drug Monitoring Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Drug Class
      • 8.3.3.2.2. By Technology
  • 8.3.4. Japan Therapeutic Drug Monitoring Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Drug Class
      • 8.3.4.2.2. By Technology
  • 8.3.5. Australia Therapeutic Drug Monitoring Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Drug Class
      • 8.3.5.2.2. By Technology

9. South America Therapeutic Drug Monitoring Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Drug Class
  • 9.2.2. By Technology
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Therapeutic Drug Monitoring Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Drug Class
      • 9.3.1.2.2. By Technology
  • 9.3.2. Argentina Therapeutic Drug Monitoring Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Drug Class
      • 9.3.2.2.2. By Technology
  • 9.3.3. Colombia Therapeutic Drug Monitoring Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Drug Class
      • 9.3.3.2.2. By Technology

10. Middle East and Africa Therapeutic Drug Monitoring Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Drug Class
  • 10.2.2. By Technology
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Therapeutic Drug Monitoring Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Drug Class
      • 10.3.1.2.2. By Technology
  • 10.3.2. Saudi Arabia Therapeutic Drug Monitoring Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Drug Class
      • 10.3.2.2.2. By Technology
  • 10.3.3. UAE Therapeutic Drug Monitoring Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Drug Class
      • 10.3.3.2.2. By Technology

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Therapeutic Drug Monitoring Market: SWOT Analysis

15. Porters Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products

16. Competitive Landscape

• 16.1. Roche AG
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. Siemens Healthcare GmbH
• 16.3. Thermo Fisher Scientific, Inc.
• 16.4. Bio-Rad Laboratories, Inc.
• 16.5. Beckman Coulter, Inc.
• 16.6. Abbott Laboratories, Inc.
• 16.7. Agilent Technologies, Inc.
• 16.8. bioMerieux, Inc.
• 16.9. Alere, Inc.

17. Strategic Recommendations

18. About Us & Disclaimer